Loading…

Phase I trial and preclinical data of ACT using neoantigen-reactive TIL for patients with advanced epithelial and ICB-resistant solid cancers

Saved in:

Bibliographic Details
Published in:	Immuno-oncology technology 2024-12, p.101030, Article 101030
Main Authors:	Palomero, Jara, Galvao, Vladimir, Creus, Immaculada, Lostes, Julia, Aylagas, Miriam, Marín-Bayo, Albert, Rotxés, Marta, Sanz, Marta, Lozano-Rabella, Maria, Garcia-Garijo, Andrea, Yuste-Estevanez, Anna, Grases, Daniela, Díaz-Gómez, Judit, González, Jonatan, Navarro, Jose Fernandez, Gartner, Jared J., Braña, Irene, Villalobos, Xenia, Bayó-Puxan, Neus, Jiménez, Jose, Palazón, Anna N., Muñoz, Susana, Villacampa, Guillermo, Piris-Giménez, Alejandro, Barba, Pere, Codinach, Margarita, Rodríguez, Luciano, Querol, Sergi, Muñoz-Couselo, Eva, Tabernero, Josep, Martín-Lluesma, Silvia, Gros, Alena, Garralda, Elena
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!